REBEKAH MOSS: Open Payments
NPI 1962464883 · BOONEVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 30 payments from 12 companies in 2025. Trend: 2023 $534 · 2024 $624 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $163 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| PFIZER INC. | 3 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| Amgen Inc. | 2 | $32 |
| Corcept Therapeutics | 2 | $31 |
| ABBVIE INC. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: CAPLYTA, REXULTI, NURTEC ODT, EVENITY, Korlym, VRAYLAR, Wegovy, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
